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 Abstract. This work showcased the chemoinformatic study of 
isoxazoline ectoparasiticides: Fluralaner (FLU) and Afoxolaner 
(AFO) interactions with l-glutamate-gated chloride channels 
(3RHW). In order to evaluate inhibition thermodynamics, 
computational approaches such as molecular docking were 
employed. Results evidenced that FLU-3RHW highest scoring pose 
presented lower Gibbs free energy and henceforth, lower Ki values 
than AFO-3RHW. The findings herein reported suggest therefore 
that computational methods might be useful to study the 
thermodynamic features of ectoparasiticides used in veterinary 
care, what might shed further light on their chemical and 
pharmacological properties. 
Keywords: ectoparasite; molecular docking; ion channel; HOMO; 
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INTRODUCTION 
Fluralaner (FLU) and Afoxolaner (AFO) are 
widely prescribed isoxazoline ectoparasiticides 
in veterinary care against flea and tick infesta-
tions. Owing to their lipophilic chemical struc-
tures, their presence in animal tissue can be ex-
tended up to twelve weeks according to dose and 
patient weight. These compounds exert their 
pharmacological activities through the inhibition 
of γ-aminobutyric acid (GABA)-gated chloride 
channels and l-glutamate-gated chloride chan-
nels which are present in ectoparasite cells [1, 2, 
3, 4]. 
FLU and AFO have remarkable efficacy as anti-
parasitic agents whose are nonetheless also as-
sociated with noteworthy safety, hence toxicity 
cases have been rarely reported. These com-
pounds are known to inhibit chlorine channels 
similarly to other antiparasitary compounds such 
as ivermectin. Amongst these channels, l-
glutamate-gated are remarkable due to their in-
volvement in ectoparasite vital functions [5, 6, 7, 
8]. 
Although literature supports the pharmacologi-
cal properties of these compounds, there was, to 
the best of our knowledge, no report regarding 
an in silico investigation of their inhibition ther-
modynamic towards their therapeutic targets. In 
this context, molecular docking strategies might 
provide important insights concerning the 
pharmacodynamics of isoxazoline ectoparasiti-
cides. As showcased by previous reports by our 
group and literature, in silico tools can be applied 
to comprehensively assess overall physicochemi-
cal features which might foment insights about 
the mechanism of action of drugs [9, 10, 11]. 
In view of the importance of better understand-
ing FLU and AFO mechanisms of action in veteri-
nary care, this work is aimed on the in silico study 
of the thermodynamics of the inhibition pro-
moted by these drugs on l-glutamate-gated chlo-
ride channels. 
 
METHODS 
In silico methods. The protocol herein depicted is 
based on previous reports by our group [10, 11] 
in which ligands were studied concerning their 
kinetic and thermodynamic parameters regard-
ing macromolecule i.e. protein/channel inhibi-
tion: FLU (4-[5-(3,5-dichlorophenyl)-5-
(trifluoromethyl)-4H-1,2-oxazol-3-yl]-2-methyl-N-[2-
oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide) 
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and AFO (4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-
5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-N-[2-oxo-2-
(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-
carboxamide) structures were minimized through 
Chimera software version 1.13 coupled to Mo-
lecular Modeling Toolkit (MMTK) and AMBER 
toolkit 4.0 prior docking studies. The same soft-
ware was used to edit protein units retrieved 
from Protein DataBank (PDB). 
Moreover, the software Python Molecular Viewer 
(PMV) version 1.5.6 was used to evaluate tor-
sion-prone regions in each analyzed molecule, 
namely: FLY and AFO, and the docking models 
were conducted using AutoDock Vina and Auto-
Dock Tools version 1.5.6. The docking models 
herein employed are based on a flexible ligand 
and a rigid receptor, therefore configuring itself 
as a semi-flexible model [12, 13, 14]. The minimi-
zation in energy conformation and HOMO surface 
calculations were performed employing MM2 
Force Field in ChemDraw3D® Pro 12. 
l-glutamate-gated chloride channel structure 
(3RHW). In this work was employed C. elegans 
glutamate-gated chloride channel receptor (PDB 
entry: 3RHW) in complex with ivermectin. The 
chemical structure of the original ligand i.e. iver-
mectin was deleted and the ligand site was used 
in the docking-grid to guide inhibition analysis. 
The docking-grid was adjusted to encompass all 
possible interaction sites where ivermectin was 
previously bound. Exhaustiveness was set to 20 
in order to render more reproducible results. 
Inhibition constants calculation. The values of 
Gibbs free energy are associated to the energy 
level of thermodynamic systems, and might be 
correlated to the feasibility of stable intermolecu-
lar interactions. Therefore, this parameter was 
analyzed and used to calculate the inhibition 
constant (Ki) through the following equation (1): 
ln iG RT K  ,     (1) 
where G  is the Gibbs free energy of the system;  
R is the gas constant and T is the temperature.  
 
This equation can be derived as shown bellow 
(2). 
i RT
G
K
e

 ,      (2) 
where e is the Euler number. 
All theoretical applications herein depicted were 
previously showcased in previous reports by our 
group [10, 11]. 
 
RESULTS AND DISCUSSION 
FLU and AFO energy minimization. In order to 
prepare each molecule for docking, their energies 
were minimized to render the lowest energy con-
former. Moreover, highest occupied molecular 
orbital (HOMO) regions were also calculated as 
well as the torsion-feasible regions. Results are 
displayed in Figure 1. 
 
 
Figure – Results of FLU and AFO energy minimization 
Notes: A) 3D Chemical structure of FLU lowest energy conformer; B) 2D chemical depiction of FLU structure; C) HOMO de-
pictions of CBP lowest energy conformer depicting low (Blue) and high (Red) electron density regions; D) 3D Chemical 
structure of AFO lowest energy conformer; E) 2D chemical depiction of AFO structure; F) HOMO depictions of AFO lowest 
energy conformer depicting low (Blue) and high (Red) electron density regions.  
All data gathered through Chimera software version 1.13. 
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Results evidenced that in both FLU and AFO low-
est energy conformers, the oxazolic moiety pre-
sents a bend shape (Figure 1). Furthermore, 
HOMO regions of the molecules showcased that 
the oxazolic moiety is also the main group which 
could be covalently bonded to a macromolecule 
in a possible coupling mechanism involving elec-
tron sharing (Figure 1). Concerning torsion-
prone regions, both in FLU and AFO, the terminal 
aliphatic chain, which present σsp3-sp3 covalent 
bounds, is the main flexible moiety. 
FLU and AFO docking to 3RHW. In order to ex-
plore FLU inhibition of 3RHW, a molecular dock-
ing approach was used. Henceforth the gridline 
for the docking study was set around the region 
originally occupied by ivermectin in the crystal-
lographic data retrieved from PDB. Figure 2 dis-
plays the highest scoring model with the dis-
tances between FLU and nearby residues meas-
ured in angstroms (Å). 
 
 
Figure 2– FLU and AFO docking to 3RHW 
Notes: Molecular docking depiction of the highest scoring model for FLU-3RHW interaction. Distances therein 
highlighted between FLU molecule (Blue, Red and Green) and nearby residues measured in angstroms (Å).  
All data gathered through Chimera software version 1.13. 
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FLU-3RHW highest scoring docking model show-
cased no hydrogen bounds (Figure 2). The close 
proximity of the ligand structure to the α-helixes 
of 3RHW, and the low Gibbs free energy associ-
ated to this conformation suggests that FLU 
molecule might stably interact with the macro-
molecule in the position therein depicted. 
Moreover, the same protocol was used to study 
AFO-3RHW interaction. Results are depicted in 
Figure 3, wherein the highest scoring model is 
showcased. 
 
 
 
Figure 3 – Results of study AFO-3RHW interaction 
Notes: Molecular docking depiction of the highest scoring model for AFO-3RHW interaction. Distances therein 
highlighted between AFO molecule (Blue, Red and Green) and nearby residues measured in angstroms (Å) 
All data gathered through Chimera software version 1.13 
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AFO-3RHW highest scoring model was located 
between the α-helixes of the pentameric-
structured moiety of the macromolecule. Fur-
thermore, the model presented a hydrogen bond 
(Figure 3). 
Considering that the docking-grids were assigned 
to encompass all possible inhibition sites in 
3RHW molecule, which were originally occupied 
by ivermectin, the presence of FLU and AFO in 
these pockets suggests interaction and might be 
correlated to the biological activities of these 
drugs [15, 16, 17, 18]. Nonetheless, FLU and AFO 
inhibition of l-glutamate-gated chloride channels 
is well reported in literature, what corroborates 
to the results herein showcased [1, 2, 3, 4].  
Furthermore, the low energy values associated to 
each pose further suggests interaction, hence 
small energy models are usually associated to 
higher stability, and therefore feasible interaction 
[19, 20, 21, 22]. Nonetheless, literature reports 
corroborate to these findings in both models [23, 
24]. 
In order to gather more information about the 
thermodynamic features of the calculated dock-
ing models and stablish correlations to their 
pharmacological applications, their Ki were calcu-
lated from the Gibbs free energy of each highest 
scoring pose. 
Inhibition constant calculation. The Ki of the low-
est energy pose for both FLU-3RHW and AFO-
3RHW was calculated and displayed bellow in 
Table 1. 
 
Table 1 – Thermodynamical properties calculated for the lowest energy pose of FLU-3RHW and AFO-3RHW 
Model Affinity,  
kcal.mol
-1
 
Ki 
cal.mol
-1
 K
-1 
10
-8
 
RMSD,  
l. b. 
RMSB, 
u. b. 
HBonds, 
ligand 
HBonds, 
receptor 
FLU-
3RHW 
-9.8 7.247 0.0 0.0 0 0 
AFO-
3RHW 
-8.9 32.808 0.0 0.0 1 1 
 
Results evidenced that the calculated Ki for FLU-
3RHW was lower than that of AFO-3RHW, what 
suggest higher thermodynamic feasibility of the 
inhibition promoted by FLU molecule. This is a 
remarkable finding, since no previous work has 
reported the difference between FLU and AFO 
interactions with their biological targets through 
computational methods. Albeit the results of this 
work suggest that FLU may interact more to l-
glutamate-gated chloride channels than AFO 
could, more investigations are needed to better 
understand the pharmacodynamics of these 
isoxazoline ectoparasiticides. 
 
CONCLUSION 
This work showcased the in silico study of FLU 
and AFO interactions with l-glutamate-gated 
chloride channels, wherein FLU-3RHW highest 
scoring pose presented lower Gibbs free energy 
and henceforth, lower Ki values than AFO-3RHW. 
The findings herein reported suggest therefore 
that computational methods might be useful to 
study the thermodynamic features of isoxazoline 
ectoparasiticides, what might shed further light 
on their chemical and pharmacological proper-
ties. 
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